200 related articles for article (PubMed ID: 25938762)
21. Dengue viremia kinetics in asymptomatic and symptomatic infection.
Matangkasombut P; Manopwisedjaroen K; Pitabut N; Thaloengsok S; Suraamornkul S; Yingtaweesak T; Duong V; Sakuntabhai A; Paul R; Singhasivanon P
Int J Infect Dis; 2020 Dec; 101():90-97. PubMed ID: 32992011
[TBL] [Abstract][Full Text] [Related]
22. Higher-temperature-adapted dengue virus serotype 2 strain exhibits enhanced virulence in AG129 mouse model.
Modak A; Mishra SR; Awasthi M; Sreedevi S; Sobha A; Aravind A; Kuppusamy K; Sreekumar E
FASEB J; 2023 Aug; 37(8):e23062. PubMed ID: 37389962
[TBL] [Abstract][Full Text] [Related]
23. Murine models of dengue virus infection for novel drug discovery.
Byrne AB; García CC; Damonte EB; Talarico LB
Expert Opin Drug Discov; 2022 Apr; 17(4):397-412. PubMed ID: 35098849
[TBL] [Abstract][Full Text] [Related]
24. Nutritional status impacts dengue virus infection in mice.
Chuong C; Bates TA; Akter S; Werre SR; LeRoith T; Weger-Lucarelli J
BMC Biol; 2020 Aug; 18(1):106. PubMed ID: 32854687
[TBL] [Abstract][Full Text] [Related]
25. A murine model of dengue virus infection in suckling C57BL/6 and BALB/c mice.
Byrne AB; García AG; Brahamian JM; Mauri A; Ferretti A; Polack FP; Talarico LB
Animal Model Exp Med; 2021 Mar; 4(1):16-26. PubMed ID: 33738433
[TBL] [Abstract][Full Text] [Related]
26. Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from a Single Clinical Viral Isolate.
Zheng Z; Li M; Liu Z; Jin X; Sun J
Virol Sin; 2020 Oct; 35(5):626-636. PubMed ID: 32451883
[TBL] [Abstract][Full Text] [Related]
27. The association between dengue viremia kinetics and dengue severity: A systemic review and meta-analysis.
Morsy S; Hashan MR; Hieu TH; Mohammed AT; Elawady SS; Ghosh P; Elgendy MA; Le HH; Hamad WMA; Iqtadar S; Dumre SP; Hirayama K; Huy NT
Rev Med Virol; 2020 Nov; 30(6):1-10. PubMed ID: 32856357
[TBL] [Abstract][Full Text] [Related]
28. Role of CD61+ cells in thrombocytopenia of dengue patients.
Noisakran S; Onlamoon N; Pattanapanyasat K; Hsiao HM; Songprakhon P; Angkasekwinai N; Chokephaibulkit K; Villinger F; Ansari AA; Perng GC
Int J Hematol; 2012 Nov; 96(5):600-10. PubMed ID: 22987294
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of liver involvement caused by two DENV-2 lineages using an immunocompetent murine model.
Jácome FC; Caldas GC; Rasinhas ADC; de Almeida ALT; de Souza DDC; Paulino AC; Leonardo R; Barth OM; Dos Santos FB; Barreto-Vieira DF
Sci Rep; 2021 May; 11(1):9723. PubMed ID: 33958631
[TBL] [Abstract][Full Text] [Related]
30. Platelets in dengue infection: more than a numbers game.
Quirino-Teixeira AC; Andrade FB; Pinheiro MBM; Rozini SV; Hottz ED
Platelets; 2022 Feb; 33(2):176-183. PubMed ID: 34027810
[TBL] [Abstract][Full Text] [Related]
31. Dengue Virus and Platelets: From the Biology to the Clinic.
Losada PX; DeLaura I; Narváez CF
Viral Immunol; 2022 Jun; 35(5):349-358. PubMed ID: 35483090
[TBL] [Abstract][Full Text] [Related]
32. Platelet activation determines the severity of thrombocytopenia in dengue infection.
Ojha A; Nandi D; Batra H; Singhal R; Annarapu GK; Bhattacharyya S; Seth T; Dar L; Medigeshi GR; Vrati S; Vikram NK; Guchhait P
Sci Rep; 2017 Jan; 7():41697. PubMed ID: 28139770
[TBL] [Abstract][Full Text] [Related]
33. Dengue encephalopathy in an adult due to dengue virus type 1 infection.
Leng X; Yang H; Zhao L; Feng J; Jin K; Liao L; Zhang F
BMC Infect Dis; 2024 Mar; 24(1):319. PubMed ID: 38491361
[TBL] [Abstract][Full Text] [Related]
34. Increased TNF-
Satria RD; Huang TW; Jhan MK; Shen TJ; Tseng PC; Wang YT; Yang ZY; Hsing CH; Lin CF
J Immunol Res; 2021; 2021():6654617. PubMed ID: 34041302
[TBL] [Abstract][Full Text] [Related]
35. Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity.
Shukla R; Ahuja R; Beesetti H; Garg A; Aggarwal C; Chaturvedi S; Nayyar K; Arora U; Lal AA; Khanna N
Sci Rep; 2023 Jan; 13(1):1026. PubMed ID: 36658277
[TBL] [Abstract][Full Text] [Related]
36. NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.
Moquin SA; Simon O; Karuna R; Lakshminarayana SB; Yokokawa F; Wang F; Saravanan C; Zhang J; Day CW; Chan K; Wang QY; Lu S; Dong H; Wan KF; Lim SP; Liu W; Seh CC; Chen YL; Xu H; Barkan DT; Kounde CS; Sim WLS; Wang G; Yeo HQ; Zou B; Chan WL; Ding M; Song JG; Li M; Osborne C; Blasco F; Sarko C; Beer D; Bonamy GMC; Sasseville VG; Shi PY; Diagana TT; Yeung BKS; Gu F
Sci Transl Med; 2021 Feb; 13(579):. PubMed ID: 33536278
[TBL] [Abstract][Full Text] [Related]
37. Liver transcriptomics reveals features of the host response in a mouse model of dengue virus infection.
Zheng W; Yan Q; Li Z; Wang X; Wu P; Liao F; Lao Z; Jiang Y; Liu X; Zhan S; Li G
Front Immunol; 2022; 13():892469. PubMed ID: 36091000
[TBL] [Abstract][Full Text] [Related]
38. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases.
Hottz ED; Oliveira MF; Nunes PC; Nogueira RM; Valls-de-Souza R; Da Poian AT; Weyrich AS; Zimmerman GA; Bozza PT; Bozza FA
J Thromb Haemost; 2013 May; 11(5):951-62. PubMed ID: 23433144
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor.
Orozco S; Schmid MA; Parameswaran P; Lachica R; Henn MR; Beatty R; Harris E
J Gen Virol; 2012 Oct; 93(Pt 10):2152-2157. PubMed ID: 22815273
[TBL] [Abstract][Full Text] [Related]
40. Murine diabetic models for dengue virus infection.
Liu X; Liu Y; Wu H; He Z; Li Z; Qin Z; Yu J; Zhu L; Wu Q; Xiao W; Shen C; Wan C; Zhang B; Zhao W
J Med Virol; 2022 Dec; 94(12):5943-5953. PubMed ID: 36000451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
